deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT04078737

Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events II (CHANCE-2)

Sponsor: Beijing Tiantan Hospital

Conditions Stroke Transient Ischemic Attack
Interventions Clopidogrel and Aspirin Ticagrelor and Aspirin
Updated 10 times since 2019 Last updated: Nov 30, 2021 Started: Sep 23, 2019 Primary completion: Jun 24, 2021 Completion: Jul 1, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Stroke and Transient Ischemic Attack and is currently completed. Beijing Tiantan Hospital leads this study, which shows 10 recorded versions since 2019 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Oct 2019 – ~Aug 2020 · 10 months · monthly snapshotActive Not Recruiting~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshotRecruiting~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshotRecruiting~Mar 2021 – ~May 2021 · 2 months · monthly snapshotRecruiting~May 2021 – ~Sep 2021 · 4 months · monthly snapshotRecruiting~Sep 2021 – ~Jan 2022 · 4 months · monthly snapshotActive Not Recruiting~Jan 2022 – ~Jul 2024 · 30 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

10 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Jan 2022 — Jul 2024 [monthly]

    Completed PHASE3

    Status: Active Not Recruiting → Completed

  5. Sep 2021 — Jan 2022 [monthly]

    Active Not Recruiting PHASE3

    Status: Recruiting → Active Not Recruiting

▶ Show 5 earlier versions

  1. May 2021 — Sep 2021 [monthly]

    Recruiting PHASE3

  2. Mar 2021 — May 2021 [monthly]

    Recruiting PHASE3

  3. Jan 2021 — Mar 2021 [monthly]

    Recruiting PHASE3

  4. Aug 2020 — Jan 2021 [monthly]

    Recruiting PHASE3

    Status: Active Not Recruiting → Recruiting

  5. Oct 2019 — Aug 2020 [monthly]

    Active Not Recruiting PHASE3

    First recorded

Sep 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Beijing Tiantan Hospital
  • Ministry of Science and Technology of the People´s Republic of China
Data source: Beijing Tiantan Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Anqing, China , Anyang, China , Baoding, China , Baoji, China , Baotou, China , Bayan Nur, China , Beijing, China , Bengbu, China , Buri, China , Changchun, China and 95 more locations